Your browser doesn't support javascript.
loading
RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both in vitro and in vivo.
Li, Jun; Liao, Dan; Wang, Fujue; Wang, Zhongwang; Li, Yueshan; Xiong, Yu; Niu, Ting.
Affiliation
  • Li J; Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Liao D; Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Wang F; Department of Hematology, The Third Hospital of Mianyang, Mianyang, China.
  • Wang Z; Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Li Y; Department of Hematology, The First Affiliated Hospital of University of South China, Hengyang, China.
  • Xiong Y; Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Niu T; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Leuk Lymphoma ; 63(5): 1167-1179, 2022 05.
Article in En | MEDLINE | ID: mdl-34865571
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: China